Atossa Therapeutics News and Activities

Atossa Therapeutics is a company listed under the stock ticker ATOS (US).

View the org chart displaying its 17 main executives

Most searched biographies at Atossa Therapeutics

• Steven Quay, Chairman of the Board and Chief Executive Officer
• Jonathan Finn, Director
• Shu-Chih Chen, Director

Popular executive movements at Atossa Therapeutics

• Kathy Puyana Theall has joined the company as Medical Director, Breast Oncology  (posted on March 22 2026).
• Adebola Giwa has joined the company as Medical Director, Rare Diseases  (posted on March 22 2026).
• Mark Daniel has joined the company as Chief Financial Officer  (posted on October 16 2025).

Click here to view some more movements at Atossa Therapeutics

Create your alert
to follow the executive moves at Atossa Therapeutics.

Atossa Therapeutics has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Atossa Therapeutics

• News Releases - Atossa Therapeutics
• Investors – Atossa Therapeutics

Social media about Atossa Therapeutics

• Atossa Therapeutics on Wikipedia, Google News & Yahoo Finance
• Atossa Therapeutics on LinkedIn, X (Twitter) & YouTube